The Division of Pediatric Endocrinology and Diabetes at Stanford is actively involved in clinical research. If you are interested in being contacted about future studies, please complete the Patient List Research Consent Form. Once completed and submitted, the information you provide will be added to our database of potential research participants.
Studies Currently Recruiting
This is a Phase 1 study to assess safety and tolerability of a DNA plasmid. The plasmid is designed to halt the immune attack on the insulin producing beta cells. The study involves 12 subcutaneous weekly injections with follow up for a year after the initial dose.
Closed Loop Therapy with Verapamil (CLVer) for Beta Cell Preservation
In this pediactirc study, we want to find out if keeping the blood sugar very close to normal will help pancreas cells that make insulin stay alive longer. The study also is testing whether a drugcalled verapamil can keep these cells healthy.
A diet study for people with T1D
Our team is conducting an exciting new research study to learn how to help young people with Type 1 diabetes achieve blood glucose goals and a healthy weight at the same time.
Stanford TrialNet is part of an international network of leading academic institutions, scientists and healthcare teams dedicated to the prevention of type 1 diabetes. We offer no cost risk screening for relatives of people with type 1 diabetes and innovative clinical studies to preserve insulin production. For additional information visit;
Studies Closed for Recruitment
Project ECHO is an pilot program working with primary care providers and adults with Type 1 Diabetes to find out what healthcare barriers prevent people from receiving diabetes care.
Stanford Diabetes Research Center
The SDRC promotes the teaching and training goals of Stanford University by training the next generation of investigators and leaders of diabetes research and care.
The aim of our basic science program is to elucidate the role of the endocrine system in both health and the development of diseases. Through this work, we hope to increase our understanding of the important physiological processes that are controlled by hormones and how alterations in hormone levels perturb the body’s homeostasis and cause disease in people. Our goal is to apply discoveries we make in the laboratory toward the development of novel therapeutics for a variety of illnesses that affect children.
You can read more about the work of faculty member Anna Gloyn and her team.
Join our database to receive study recruitment emails. Click the button below.